We are live on ! Find out more
OFIX icon

Orthofix Medical

149 hedge funds and large institutions have $635M invested in Orthofix Medical in 2022 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 46 increasing their positions, 55 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 9

10% more funds holding

Funds holding: 135149 (+14)

5% more capital invested

Capital invested by funds: $603M → $635M (+$31.4M)

0.54% less ownership

Funds ownership: 98.35%97.82% (-0.54%)

16% less repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 55

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $65K

Holders
149
Holders Change
+14
Holders Change %
+10.37%
% of All Funds
2.34%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
24
Increased
46
Reduced
55
Closed
9
Calls
Puts
$65K
Net Calls
-$65K
Net Calls Change
+$143K

OFIX Hedge Fund Activity: Q1 2022 in Review

149 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in Orthofix Medical (OFIX) for Q1 2022, worth a combined $635M — up 5.2% from $603M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new OFIX positions and 9 closed out — a net gain of 15 holders — while 46 added to existing stakes and 55 trimmed.

The largest buyer was Endurant Capital Management, adding an estimated $13.4M. The largest seller was Oakview Capital Management, exiting entirely with an estimated $8.73M sold.

  • 149 institutional investors held Orthofix Medical (OFIX) as of Q1 2022, up from 135 in Q4 2021.
  • Funds reported $635M of Orthofix Medical stock for Q1 2022, up 5.2% quarter-over-quarter.
  • 24 funds opened new Orthofix Medical positions in Q1 2022 and 9 closed out, a net change of +15 holders.
  • The largest Orthofix Medical buyer in Q1 2022 was Endurant Capital Management, an estimated $13.4M added.
  • The largest Orthofix Medical seller in Q1 2022 was Oakview Capital Management, an estimated $8.73M sold.

Based on aggregated 13F filings for Q1 2022.